DIA442.36+2.21 0.50%
SPX6,263.70+19.94 0.32%
IXIC20,730.49+52.69 0.26%

Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Benzinga·06/16/2025 10:00:21
Listen to the news

Shares of Incyte Corporation (NASDAQ:INCY) rose sharply in today's pre-market trading.

QIAGEN and Incyte disclosed a precision medicine collaboration to develop companion diagnostics for patients with mutant CALR-expressing Myeloproliferative Neoplasms (MPNs).

Incyte shares jumped 9.6% to $74.25 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • TMD Energy Limited (NYSE:TMDE) surged 203% to $3.85 in pre-market trading after gaining over 75% on Friday.
  • Regencell Bioscience Holdings Limited (NASDAQ:RGC) shares jumped 169.6% to $43.00 in pre-market trading after dipping 97% on Friday.
  • Battalion Oil Corporation (NASDAQ:BATL) jumped 166% to $4.37 in pre-market trading after gaining 15% on Friday.
  • OceanPal Inc (NASDAQ:OP) gained 91.9% to $3.09 in pre-market trading after gaining 123% on Friday.
  • K Wave Media Ltd. (NASDAQ:KWM) rose 69.3% to $4.91 in pre-market trading after tumbling over 50% on Friday.
  • New Era Helium, Inc. (NASDAQ:NEHC) climbed 51.1% to $0.8206 in pre-market trading after declining around 10% on Friday. New Era Helium, last week, announced that its joint venture with Sharon AI, Texas Critical Data Centers, is in active discussions with enterprises to anchor its planned AI infrastructure buildout in Texas.
  • EchoStar Corporation (NASDAQ:SATS) rose 47.8% to $24.83 in pre-market trading after falling 7% on Friday.
  • AIRO Group Holdings, Inc. (NASDAQ:AIRO) surged 30.2% to $31.25 in pre-market trading after jumping 140% on Friday. AIRO Group priced its $60 million initial public offering of 6 million common shares at $10 per share.
  • IperionX Limited (NASDAQ:IPX) gained 13% to $29.31 in pre-market trading after falling 5% on Friday.

Losers

  • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares tumbled 31.4% to $24.86 in pre-market trading after the company suspended ELEVIDYS shipments and paused ENVISION trial after second fatal liver failure in non-ambulatory Duchenne patients.
  • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) dipped 26.5% to $0.2228 in pre-market trading after falling 10% on Friday.
  • KULR Technology Group, Inc. (NYSE:KULR) shares fell 21.9% to $0.8980 in pre-market trading after the company reported a 1-for-8 reverse stock split.
  • MicroAlgo Inc. (NASDAQ:MLGO) declined 17% to $0.7141 in pre-market trading after dipping 22% on Friday.
  • Greenlane Holdings, Inc. (NASDAQ:GNLN) fell 15.9% to $0.0085 in pre-market trading after tumbling 34% on Friday.
  • Gold Royalty Corp. (NYSE:GROY) dipped 14.7% to $1.95 in pre-market trading. Canaccord Genuity, on June 11, initiated a Buy rating on the stock and announced a $3 price target.
  • Catheter Precision, Inc. (NYSE:VTAK) declined 9.8% to $0.3150 in pre-market trading after dipping 15% on Friday.
  • Solid Biosciences Inc. (NASDAQ:SLDB) fell 8% to $4.15 in pre-market trading. JMP Securities, on June 6, reiterated its Market Outperform rating on the stock and maintained a $15 price target.
  • FiEE, Inc. (NASDAQ:MINM) declined 7% to $2.47 in pre-market trading.
  • Omada Health, Inc. (NASDAQ:OMDA) fell 5.4% to $16.18 in pre-market trading.

Now Read This:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.